echoloc

Velsera Tech Stack

Precision medicine software built from Seven Bridges and Pierian merger

Biotechnology Research Charlestown, MA 501–1,000 employees Founded 2023 Privately Held

Velsera emerged in 2023 from the combination of Seven Bridges and Pierian, positioning itself in drug discovery, IVD development, and clinical NGS interpretation. The hiring shape—finance-heavy (6 roles) with concentrated director-level placements (5)—reflects post-merger integration work, while active projects centered on FedRAMP authorization, cloud security controls, and Seven Bridges platform implementations for research data commons signal a compliance-first infrastructure posture. Pain-point data confirms internal friction: slow software delivery, reporting inefficiency, and customer churn risk all appear in the top challenges.

Tech Stack 32 technologies

Core StackAWS Java Python MongoDB Linux Go CloudFormation Terraform Ansible Prometheus CloudWatch Grafana Elasticsearch Jenkins MySQL PostgreSQL GitLab NetSuite Oracle GitHub Bash GCP Azure AWS EKS AWS ECS AWS CodePipeline FedRAMP ISO 27001 ISO 27017 Spring Boot+2 more

What Velsera Is Building

Challenges

  • Improving close and reporting efficiency
  • Moving too slow
  • Timely cash collections
  • High-impact risk assessments
  • Customer due diligence requests
  • Automation of grc activities
  • Slow software delivery
  • Streamlining accounting processes
  • Customer churn risk
  • Account renewal challenges

Active Projects

  • Year-end audit
  • Policy and procedure implementation
  • Automation of product deployments
  • Implementing monitoring strategy
  • Fedramp authorization
  • Cloud security controls
  • Enterprise security policy development
  • Seven bridges platform implementation for cancer research data commons
  • Seven bridges platform implementation for biodata catalyst
  • System implementation or upgrades

Hiring Activity

Accelerating15 roles · 15 in 30d

Department

Finance
6
Engineering
5
Customer-Success
1
Marketing
1
Ops
1
Product
1
Security
1

Seniority

Director
5
Senior
4
Manager
3
Junior
1
Lead
1
Mid
1
Principal
1

Notable leadership hires: Technical Lead

Company intelligence

Find more companies like Velsera by tech stack, pain points and active projects

Get started free

About Velsera

Velsera provides software and professional services for multimodal data harmonization, drug discovery analytics, IVD validation and approval workflows, and clinical NGS interpretation. The company operates across precision medicine and life sciences, serving pharma, biotech, and clinical organizations. Founded in 2023 through a merger, Velsera spans 501–1,000 employees across the United States and India, with headquarters in Charlestown, MA. The technology stack emphasizes AWS, GCP, and Azure infrastructure (EKS, ECS, CloudFormation, Terraform) alongside Java, Python, and Go services, with compliance certifications in FedRAMP, ISO 27001, and ISO 27017.

HeadquartersCharlestown, MA
Company Size501–1,000 employees
Founded2023
Hiring MarketsIndia, United States

Frequently Asked Questions

What is Velsera's tech stack?

AWS (EKS, ECS, CloudFormation), GCP, Azure, Java, Python, Go, PostgreSQL, MongoDB, Elasticsearch, Terraform, Ansible, Prometheus, Grafana, Spring Boot, and Jenkins for CI/CD. FedRAMP and ISO 27001/27017 certified.

What is Velsera working on?

FedRAMP authorization, cloud security controls, Seven Bridges platform implementations for cancer research data commons and BioData Catalyst, deployment automation, and monitoring strategy implementation.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size